Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

Culotte stenting for the treatment of unprotected distal LM with compromised Lcx ostium: the difficulty to cross stents cell with balloons

18 May 2021 – From EuroPCR 2021

In this session, analyze culotte stenting in patient with significant distal left main stenosis.

Culotte stenting for the treatment of unprotected distal LM with compromised Lcx ostium: the difficulty to cross stents cell with balloons

Surgery or PCI?

18 May 2021 – From EuroPCR 2021

In this session, discover a case when the surgeon ́s ambitions are higher than his courage.

Surgery or PCI?

Complex PCI in coronary calcified lesions, the right tools and techniques

18 May 2021 – From EuroPCR 2021

Watch this session presented by Flavio Luciano Ribichini, Colm Hanratty, Mark Kennedy, Emile Mehanna, David Leistner and Akiko Maehara in order to learn practical tips to assess calcified lesions with IVUS, to discuss the device selection for calcium treatment to improve patient outcome, and to know more about SYNERGY MEGATRON,...

Complex PCI in coronary calcified lesions, the right tools and techniques

Addressing diabetes globally with an innovative solution

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roxana Mehran, Luca Testa and Alexandre Abizaid in order to understand the need to address diabetes with a dedicated solution, to learn how the DES+DCB platform can help counter DM in PCI, and to get insights into the ongoing and upcoming clinical programs.

View...

Addressing diabetes globally with an innovative solution

XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES

18 May 2021 – From EuroPCR 2021

Watch this session presented by Luca Testa in order to know about XLIMIT randomised clinical trial, and to learn about Xlimus DES stent with Sirolimus and bioabsorbable polymer coating.

XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES

The latest on the prevail drug-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Azeem Latib and Antonio Colombo in order to reflect on the latest information on Prevail DCB and study, to explore DCB technology and hear the expert-recommended indications, and to gain insights through an interesting PI case using Prevail DCB.

The latest on the prevail drug-coated balloon

SELUTION DeNovo study: powered to change medical practice

18 May 2021 – From EuroPCR 2021

Watch this session presented by Christian Spaulding in order to gain insight into how the SELUTION DeNovo study could change medical practice, to understand the strategy and what differentiates the SELUTION DeNovo study, and to learn about the study design and key milestones.

SELUTION DeNovo study: powered to change medical practice

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

FFR-guided PCI optimisation directed by high-definition IVUS

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the rationale of low post-PCI FFR, to learn if and how post-PCI FFR can be improved, and to know more about the risk of post-PCI optimisation.

FFR-guided PCI optimisation directed by high-definition IVUS